Results 1 to 10 of about 399,242 (368)

Bioconjugated oligonucleotides: recent developments and thera-eutic applications [PDF]

open access: yesBioconjugate Chemistry, American Chemical Society, 2019, 30, pp.366-383, 2020
Oligonucleotide-based agents have the potential to treat or cure almost any disease, and are one of the key therapeutic drug classes of the future. Bioconjugated oligonucleotides, a subset of this class, are emerging from basic research and being successfully translated to the clinic.
S. Benizri   +5 more
arxiv   +3 more sources

The delivery of therapeutic oligonucleotides [PDF]

open access: yesNucleic Acids Research, 2016
The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the approval of the first antisense drug and with promising developments in late stage clinical trials using siRNA or splice switching oligonucleotides ...
R. Juliano
semanticscholar   +4 more sources

Antisense oligonucleotides [PDF]

open access: yesNeurology Genetics, 2019
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in ...
Daniel R. Scoles, E. Minikel, S. Pulst
semanticscholar   +4 more sources

Dendriplex-Impregnated Hydrogels With Programmed Release Rate

open access: yesFrontiers in Chemistry, 2022
Hydrogels are biocompatible matrices for local delivery of nucleic acids; however, functional dopants are required to provide efficient delivery into cells. In particular, dendrimers, known as robust nucleic acid carriers, can be used as dopants. Herein,
Evgeny Apartsin   +8 more
doaj   +1 more source

Making Oligonucleotide Conjugates and Breaking Oligonucleotides [PDF]

open access: yesNucleic Acids Symposium Series, 2007
Presented is our most recent work on synthesis and properties of oligonucleotide analogues and conjugates These include 2'-carbamoylmethyl derivatives, peptideoligonucleotide conjugates and conjugates made to combine Watson-Crick and non-Watson-Crick interactions as well as conjugates with RNA-cleaving groups.
Esther Yeheskiely   +4 more
openaire   +3 more sources

Modular Synthesis of Trifunctional Peptide-oligonucleotide Conjugates via Native Chemical Ligation

open access: yesFrontiers in Chemistry, 2021
Cell penetrating peptides (CPPs) are being increasingly used as efficient vectors for intracellular delivery of biologically active agents, such as therapeutic antisense oligonucleotides (ASOs).
Mohadeseh Dastpeyman   +5 more
doaj   +1 more source

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

open access: yesJournal of Clinical Medicine, 2020
Antisense oligonucleotides (ASOs) bind sequence specifically to the target RNA and modulate protein expression through several different mechanisms. The ASO field is an emerging area of drug development that targets the disease source at the RNA level ...
Karishma Dhuri   +6 more
semanticscholar   +1 more source

Modeling of nucleobase/oligonucleotide interaction with graphene and graphene oxide: the role of charging and/or oxidizing the graphene surface [PDF]

open access: yesMol. Cryst. Liq. Cryst. 2020, Vol. 697(1), 49-59, 2021
We analyze the influence of the charge and the degree of oxidation of the surface of graphene (Gr) on its interaction with cytosine and oligonucleotide r(C)10. This is a computational study involving DFT calculations and molecular dynamics simulations. It is shown that cytosine interacts stronger with graphene oxide (GO) than with Gr, while the energy ...
arxiv   +1 more source

Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation

open access: yesCells, 2023
Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a crucial role in maintaining normal homeostatic processes under the pathogenesis of various inflammatory and autoimmune diseases.
Dhanu Gupta   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy